Fischer Medical Ventures Ltd.

Financial

	Fischer Medical	GHCL	Styrenix Performance
Operational Metrics
Financials
5 yr Average ROE	39.11 %	21.61 %	24.53 %
5yr average Equity Multiplier	-0.03	1.58	1.76
5yr Average Asset Turnover Ratio	0.32	0.78	1.72
5yr Avg Net Profit Margin	-3.86 %	18.06 %	9.68 %
Price to Book	64.8	1.77	6.04
P/E	0.0	9.38	21.28
5yr Avg Cash Conversion Cycle	254.2 Days	25.48 Days	39.88 Days
Inventory Days	25.95 Days	83.81 Days	50.15 Days
Days Receivable	200.41 Days	19.54 Days	49.82 Days
Days Payable	8.02 Days	87.15 Days	61.0 Days
5yr Average Interest Coverage Ratio	3.82	20.51	38.91
5yr Avg ROCE	20.39 %	22.07 %	31.35 %
5yr Avg Operating Profit Margin	5.78 %	25.83 %	14.97 %
5 yr average Debt to Equity	-1.28	0.26	0.09
5yr CAGR Net Profit	n/a	14.89 %	55.69 %
5yr Average Return on Assets	-161.47 %	14.57 %	16.03 %
Shareholdings
Promoter Holding	62.81 %	19.04 %	46.24 %
Share Pledged by Promoters	0.0	1.1 %	0.0
Change in Promoter Holding (3 Yrs)	62.81 %	-0.03 %	-28.76 %
Change in Mutual Fund Holding (3 Yrs)	0.0	-6.35 %	6.28 %

Business

	Fischer Medical	GHCL	Styrenix Performance
Product Wise Break-Up	Product Wise Break-Up Chemicals 100.0 0 Soda Ash 0 Consumer products 0 Polystyrene 0 Specialties 0	Product Wise Break-Up Soda Ash 98.31 Consumer Durable 1.69 Polystyrene 0 Specialties 0 0 Chemicals 0	Product Wise Break-Up Soda Ash 0 Consumer products 0 Polystyrene 32.59 Specialties 67.41 0 Chemicals 0